Furthermore, a heightened ratio of luteinizing hormone to follicle-stimulating hormone (LH/FSH) in patients with PCOS results in hormonal dysregulation and atypical aromatase expression, subsequently elevating androgen concentrations and enhancing AMH secretion from granulosa cells (GCs) (20). Here, BRD2 is linked to polycystic ovary syndrome.